Sign in →

Test Code MSP3 Multiple Sclerosis (MS) Cascade, Serum and Spinal Fluid


Specimen Required


Both serum and spinal fluid are required. Spinal fluid must be obtained within 1 week of serum collection.

 

Specimen Type: Spinal fluid (CSF)

Container/Tube: Sterile vial

Specimen Volume: 1 mL

Collection Instructions:

1. Submit CSF from collection vial number 4 (preferred); vial number 1, 3, 2 are also acceptable (in this order).

2. Label specimen as spinal fluid.

 

Specimen Type: Serum

Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL Serum

Collection Instructions:

1. Within 2 hours of collection, centrifuge and aliquot serum into a plastic vial.

2. Label specimen as serum.


Useful For

Diagnosing multiple sclerosis, especially helpful in patients with equivocal clinical or radiological findings

Profile Information

Test ID Reporting Name Available Separately Always Performed
KCSFP Kappa Free Light Chain, CSF Yes, (KCSF) Yes
XSRM Additional sample for reflex OLIGS No Yes

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
OLIGS Serum Bands Yes, (Order OLIG, submit CSF and Serum) No
OLIGC CSF Bands Yes, (Order OLIG, submit CSF and Serum) No

Testing Algorithm

Kappa free light-chain testing will be performed by nephelometry on cerebral spinal fluid (CSF) samples. When kappa free light-chain testing indicates either borderline or positive results (≥0.0600 mg/dL), the oligoclonal banding test will be performed at an additional charge.

 

If the time of testing exceeds the specimen stability for oligoclonal banding tests, only kappa free light-chain testing will be performed. Kappa free light-chain testing will only be performed within specimen stability.

 

For more information see Central Nervous System Demyelinating Disease Diagnostic Algorithm.

Method Name

KCSFP: Nephelometry

OLIGC, OLIGS: Isoelectric Focusing (IEF) with IgG Immunoblot Detection

Reporting Name

Multiple Sclerosis Cascade

Specimen Type

CSF
Serum

Specimen Minimum Volume

Serum, Spinal fluid: 0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
CSF Frozen (preferred) 14 days
  Refrigerated  72 hours
  Ambient  24 hours
Serum Frozen (preferred) 14 days
  Ambient  14 days
  Refrigerated  14 days

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Gross icterus OK

Clinical Information

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease characterized by visual, motor, and sensory disturbances. The diagnosis of MS is dependent on clinical, radiological, and laboratory findings. Increased intrathecal immunoglobulin synthesis is an important laboratory finding in MS. Kappa free light chains (kFLCs) are produced in excess during immunoglobulin synthesis and may be detected quantitatively in cerebrospinal fluid (CSF). CSF-restricted oligoclonal bands (OCBs), identified by isoelectric focusing with IgG-specific detection of paired CSF and serum, provide qualitative evidence of intrathecal IgG synthesis.

 

This profile uses direct CSF kFLC concentration as an initial quantitative test and incorporates reflex OCB testing according to prespecified kFLC concentration thresholds. This approach was developed to provide a rapid, objective initial assessment while selectively using the more labor-intensive OCB method when additional evidence of intrathecal IgG synthesis may be informative.

 

Cerebrospinal fluid kFLC concentration, the kFLC index, and OCB testing are related but distinct approaches. The kFLC index incorporates paired CSF and serum kFLC and albumin measurements to account for systemic kFLC concentration and blood-CSF barrier permeability. The 2024 McDonald criteria recognize the kFLC index as an alternative to CSF-restricted OCBs for establishing positive CSF.(1) This profile does not calculate the kFLC index.

 

Neither increased CSF kFLC concentration nor CSF-restricted OCBs are specific for MS. Abnormal results may occur in other inflammatory, infectious, autoimmune, malignant, or neurologic disorders and should be interpreted together with the clinical presentation and imaging findings.

Reference Values

KAPPA FREE LIGHT CHAIN

Medical decision point: 0.1000 mg/dL

Positive: ≥0.1000 mg/dL

Borderline: 0.0600 mg/dL-0.0999 mg/dL

Negative <0.0600 mg/dL

 

OLIGOCLONAL BANDS:

<2 bands

Interpretation

The multiple sclerosis (MS) cascade begins with measurement of CSF kFLC concentration. Results less than 0.0600 mg/dL are considered negative and do not reflex to oligoclonal band testing. Results greater than or equal to 0.0600 mg/dL trigger reflex testing for CSF-restricted oligoclonal bands (OCBs).

 

This strategy combines the rapid, quantitative measurement of CSF kFLC with selective use of oligoclonal band testing. Neither increased CSF kFLC concentration nor CSF-restricted OCBs are specific for MS. Results should be interpreted together with the clinical presentation and imaging findings.

 

The kFLC index is a related but distinct measurement and is not calculated as part of this profile.

 

The 2024 McDonald criteria recognize intrathecal kFLC synthesis as an alternative to CSF-restricted OCBs for demonstrating a positive CSF result.(1) The recommended approach is calculation of the kFLC index:

kFLC index = (CSF kFLC / serum kFLC) / (CSF albumin / serum albumin)

The calculation requires paired CSF and serum kFLC and albumin measurements. A kFLC index greater than or equal to 6.1 is the recommended threshold for positive CSF when validated assays are used.

 

Mayo Clinic Laboratories provides the Kappa Index Calculator to facilitate calculation of the index and determine whether the result meets the greater than or equal to 6.1 threshold. A positive kFLC index supports intrathecal immunoglobulin synthesis but is not specific for MS and should be interpreted with clinical and imaging findings.

Cautions

Increased intrathecal immunoglobulin synthesis may occur in other inflammatory central nervous system diseases, and therefore, these assays are not specific for multiple sclerosis.

 

In patients with hypogammaglobulinemia or who are receiving B cell depleting therapy (eg. anti-CD20), the kappa index or oligoclonal banding may be more informative than absolute cerebrospinal fluid (CSF) kappa free light chain concentrations. Interpretation should consider serum kappa concentration and CSF/serum albumin quotient, particularly in the presence of blood-CSF barrier disruption or profound immunosuppression.

Method Description

Kappa free light chain:

Kappa free light chain is measured by nephelometric method in which the light scattered onto the antigen-antibody complexes is measured. The intensity of the measured scattered light is proportional to the amount of antigen-antibody complexes in the sample under certain conditions.(Instruction manual: Siemens Nephelometer II, Siemens, Inc, 07/2019)

 

Oligoclonal banding:

The oligoclonal banding assay requires paired cerebrospinal fluid (CSF) and serum samples. Unconcentrated CSF and diluted serum are electrophoresed by isoelectric focusing. The separated IgG bands are visualized by an IgG immunoblot, and oligoclonal bands present in the CSF and not in the serum are reported. The assay uses reagents from Helena Laboratories.(Saadeh RS, Ramos PA, Algeciras-Schimnich A, Flanagan EP, Pittock SJ, Willrich MA. An update on laboratory-based diagnostic biomarkers for multiple sclerosis and beyond. Clin Chem. 2022;68[9]:1134-1150. doi:10.1093/clinchem/hvac061)

Day(s) Performed

Monday through Friday

Report Available

3 to 5 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

83521

83916 x2 (if appropriate)

LOINC Code Information

Test ID Test Order Name Order LOINC Value
MSP3 Multiple Sclerosis Cascade 100757-4

 

Result ID Test Result Name Result LOINC Value
KCSFP Kappa Free Light Chain, CSF 48774-4
XSRM Additional sample for Reflex OLIGS No LOINC Needed